Blue California Expands Natural Flavor and Fragrance Portfolio with Production of Clean, Natural, and Sustainable Nerolidol

Rancho Santa Margarita, Calif., Dec. 15, 2021 (GLOBE NEWSWIRE) — Blue California announced the expansion of its natural flavor and fragrance portfolio of captive ingredients by producing a clean, sustainable nerolidol. Nerolidol is a rare sesquiterpene alcohol ubiquitous in nature and found in many flowers and plants, particularly in Seville orange flower, also known as […]

Nikkiso Clean Energy & Industrial Gases Group Becomes Ambassador Member of California Fuel Cell Partnership

TEMECULA, Calif., Dec. 15, 2021 (GLOBE NEWSWIRE) — Nikkiso Clean Energy & Industrial Gases Group (Group), a subsidiary of Nikkiso Co., Ltd (Japan), is proud to announce they have joined the California Fuel Cell Partnership (CaFCP) as an Ambassador. The association is driving to establish 200 hydrogen fueling stations by 2025 for a sustainable future […]

Adagio Therapeutics annonce une réduction de l’activité neutralisante in vitro de l’ADG20 contre le variant Omicron du virus SARS-CoV-2

Les données in vitro précédemment rapportées démontrant que les mutations Omicron individuelles n’étaient pas associées à l’échappement de l’ADG20 ne se traduisent pas par des essais Omicron sur des souches authentiques et des pseudovirus WALTHAM, Mass., 14 déc. 2021 (GLOBE NEWSWIRE) — Adagio Therapeutics, Inc. (Nasdaq : ADGI), une société biopharmaceutique au stade clinique axée sur […]

Casio to Release G-SHOCK Collaboration Models with the TV documentary series Matchday: Inside FC Barcelona

TOKYO, Dec. 15, 2021 /PRNewswire/ — Casio Computer Co., Ltd. announced today the latest additions to its G-SHOCK brand of shock-resistant watches. The GBD-H1000BAR and GBD-100BAR are collaboration models celebrating Matchday: Inside FC Barcelona, a documentary featuring the inner world of the famed Spanish football club. The base models for the two new watches are […]

Adagio Therapeutics Relata Redução na Atividade Neutralizante In Vitro do ADG20 Contra a Variante Omicron SARS-CoV-2

Dados in vitro relatados anteriormente que demonstram que as mutações individuais do Omicron não estavam associadas à fuga de ADG20 não se confirmam nos ensaios autênticos de Omicron e de Pseudovírus WALTHAM, Mass., Dec. 14, 2021 (GLOBE NEWSWIRE) — A Adagio Therapeutics, Inc., (Nasdaq: ADGI) uma empresa biofarmacêutica de estágio clínico focada na descoberta, desenvolvimento […]